NiKang Therapeutics
PrivateLast Round
Series C
May 26, 2021
Total Funding Raised
$260M
Momentum Score
25 /100
Company Overview
Nikang Therapeutics is a biotechnology company dedicated to discovering and developing innovative small molecule oncology medicines aimed at addressing cancer and fulfilling unmet medical needs through advanced insights into disease biology and molecular pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NiKang Therapeutics Comps
Public and private peers based on sector, stage, and business model.
NiKang Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 26, 2021 | ||||
| Series B | Sep 14, 2020 |
Key People
Founding team and executive leadership
NiKang Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C |
| Matrix | Series B, Series C |
| Janus Henderson Group | Series C |
| RA Capital Management | Series C |
| Perceptive Advisors | Series C |
| Octagon Capital Advisors | Series B, Series C |
| Ally Bridge Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 207% MoM.
- Dec 11, 2025
Presented cancer therapy NKT5097 at SABCS 2025.
NiKang Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NiKang Therapeutics's valuation, stock price, and market status.
